Jeong Ah Hwang

Jeong Ah Hwang

Auto-generated profile, based on publicly available information

Jeong Ah Hwang

Department of Radiology and Center for Imaging Sciences, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2024 in Liver International
Verified
Journal Article
Open access
KGKyowon Gu
Kyowon Gu
JLJeong Hyun Lee
Jeong Hyun Lee
JSJaeseung Shin
Jaeseung Shin
JHJeong Ah Hwang
Jeong Ah Hwang
JMJi Hye Min
Ji Hye Min
SBSung Hwan Bae
Sung Hwan Bae
Background and Aims: The Liver Imaging Reporting and Data System (LI‐RADS) offers a standardized approach for imaging hepatocellular carcinoma. However, the diverse styles and structures of radiology reports complicate automatic data extraction. Large language models hold the potential for structured data extraction from free‐text reports. Our objective was to evaluate the performance of Generative Pre‐trained Transformer (GPT)‐4 in extracting LI‐RADS features and categories from free‐text liver magnetic resonance imaging (MRI) reports.Methods: Three radiologists generated 160 fictitious free‐text liver MRI reports written in Korean and English, simulating real‐world practice. Of these, 20 were used for prompt engineering, and 140 formed the internal test cohort. Seventy‐two genuine reports, authored by 17 radiologists were collected and de‐identified for the external test cohort. LI‐RADS features were extracted using GPT‐4, with a Python script calculating categories. Accuracies in each test cohort were compared.Results: On the external test, the accuracy for the extraction of major LI‐RADS features, which encompass size, nonrim arterial phase hyperenhancement, nonperipheral ‘washout’, enhancing ‘capsule’ and threshold growth, ranged from .92 to .99. For the rest of the LI‐RADS features, the accuracy ranged from .86 to .97. For the LI‐RADS category, the model showed an accuracy of .85 (95% CI: .76, .93).Conclusions: GPT‐4 shows promise in extracting LI‐RADS features, yet further refinement of its prompting strategy and advancements in its neural network architecture are crucial for reliable use in processing complex real‐world MRI reports.

1 October 2021 in Ultrasonography
Verified
Journal Article
Open access
PDF file
JHJeong Ah Hwang
Jeong Ah Hwang
WJWoo Kyoung Jeong
Woo Kyoung Jeong
JMJi Hye Min
Ji Hye Min
YKYeun-Yoon Kim
Yeun-Yoon Kim
NHNam Hun Heo
Nam Hun Heo
HLHyo Keun Lim
Hyo Keun Lim
Purpose: The aim of this study was to evaluate the association of contrast-enhanced ultrasound (CEUS) features using Sonazoid for liver nodules with Liver Imaging Reporting and Data System (LI-RADS) categories and to identify the usefulness of Kupffer-phase images.Methods: This retrospective study was conducted in 203 patients at high risk of hepatocellular carcinoma (HCC) who underwent CEUS with Sonazoid from 2013 to 2016. Nodule enhancement in the arterial, portal venous, late, and Kupffer phases; CEUS LI-RADS major features; and Kupffer-phase defects were evaluated. According to the computed tomography/magnetic resonance imaging (CT/MRI) LI-RADS v2018, all nodules were assigned an LR category (n=4/33/99/67 for LR-M/3/4/5) and comparisons across LR categories were made. We defined modified CEUS LI-RADS as using Kupffer-phase defects as an alternative to late and mild washout in CEUS LI-RADS and compared the diagnostic performance for HCC.Results: On CEUS of 203 nodules, 89.6% of CT/MRI LR-5 and 85.9% of LR-4 nodules showed hyperenhancement in the arterial phase, while 57.6% of LR-3 nodules showed hyperenhancement. Among the CT/MRI LR-5 nodules that showed arterial phase hyperenhancement or isoenhancement, 59.7% showed hypoenhancing changes from the portal venous phase, 23.9% from the late phase, and 13.4% additionally in the Kupffer phase. The modified CEUS LI-RADS showed higher sensitivity than CEUS LI-RADS (83.2% vs. 74.2%, P=0.008) without compromising specificity (63.6% vs. 69.7%, P=0.500).Conclusion: The Kupffer phase best shows hypoenhancing changes in LR-5 lesions and is expected to improve the sensitivity for HCC in high-risk patients.

1 August 2023 in Radiology
Verified
Journal Article
Closed access
SLSunyoung Lee
Sunyoung Lee
JLJi Eun Lee
Ji Eun Lee
JHJeong Ah Hwang
Jeong Ah Hwang
HSHye Jung Shin
Hye Jung Shin
Background Ovarian-Adnexal Reporting and Data System (O-RADS) US provides a standardized method with which to stratify lesions into risk of malignancy categories, which is crucial for proper management. Purpose To perform a systematic review and meta-analysis to estimate malignancy rates for each O-RADS US score and evaluate the diagnostic performance of combined O-RADS US scores 4 and 5 in the diagnosis of malignancy. Materials and Methods A systematic literature search from the inception of the MEDLINE, EMBASE, and Web of Science databases through January 27, 2023, was performed for articles that reported using the O-RADS US stratification system and included malignancy rates per each O-RADS score. Bivariate random-effects models were used to determine the pooled malignancy rates for each O-RADS US score and to obtain summary estimates of the diagnostic performance of combined O-RADS US scores 4 and 5 in the diagnosis of malignant lesions. Results The final analysis included 18 studies consisting of 11 605 patients and 11 818 ovarian-adnexal lesions, with 2996 malignant (25.4%) and 8822 benign (74.6%) lesions. No malignant lesions were reported in O-RADS 1 category. The pooled percentages of malignancy were 0.6% (95% CI: 0.3, 1.0) for O-RADS 2, 3.9% (95% CI: 2.5, 5.4) for O-RADS 3, 43.5% (95% CI: 33.8, 53.2) for O-RADS 4, and 87.3% (95% CI: 83.0, 91.7) for O-RADS 5. The pooled sensitivity and specificity of combined O-RADS scores 4 and 5 in the diagnosis of malignant lesions were 95.6% (95% CI: 94.0, 97.2) and 76.6% (95% CI: 70.4, 82.7), respectively. Conclusion Each O-RADS US score provided the intended probability of malignant lesions as outlined by the O-RADS risk stratification system. When O-RADS US scores 4 and 5 were combined as a predictor for malignancy, O-RADS US showed a high sensitivity and moderate specificity. Clinical trial registration no. CRD42022352166 © RSNA, 2023 Supplemental material is available for this article.

1 January 2023 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
WJWoo Kyoung Jeong
Woo Kyoung Jeong
HKHyo-Jin Kang
Hyo-Jin Kang
SCSang Hyun Choi
Sang Hyun Choi
MPMi-Suk Park
Mi-Suk Park
MYMi Hye Yu
Mi Hye Yu
SLSang Min Lee
Sang Min Lee
Jeong WK, et al. Korean J Radiol. 2023 Jun;24(6):482-497. https://doi.org/10.3348/kjr.2023.0324

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JMJi Yoon Moon
Ji Yoon Moon
JMJi Hye Min
Ji Hye Min
YKYoung Kon Kim
Young Kon Kim
DCDonglk Cha
Donglk Cha
JHJeong Ah Hwang
Jeong Ah Hwang
HWHo-Jeong Won
Ho-Jeong Won
Moon JY, et al. Korean J Radiol. 2021 Jul;22:e98. https://doi.org/10.3348/kjr.2020.1428

1 June 2025 in Radiology
Verified
Journal Article
Closed access
RARobert G. Adamo
Robert G. Adamo
CPChristian B. van der Pol
Christian B. van der Pol
MAMostafa Alabousi
Mostafa Alabousi
ELEric Lam
Eric Lam
JSJean-Paul Salameh
Jean-Paul Salameh
MMMatthew D. F. McInnes
Matthew D. F. McInnes
This meta-analysis showed that most major feature combinations in the same CT/MRI Liver Imaging Reporting and Data System category had similar positive predictive values for hepatocellular carcinoma in patients at high risk for cancer, with the exception of five combinations from LR-3 to LR-5.